Cell Reports Medicine · 2024 · 11 citations · 50 references
AgricultureNutritionNutritional SciencesClinical NutritionHuman NutritionNutritional BiochemistryBiomarkers Of Liver InjuryHepatic PathophysiologyLiver DiseaseMetabolic Liver DiseaseNutrition In Liver DiseaseWeight ManagementGut Microbiota CompositionGut Microbiota DysbiosisGut Microbiota EffectsLiver Injury ResponseMetabolic Response To DietPlacebo-controlled Efficacy AssessmentPrimary Outcome AnalysisSteatosis Biomarkers
Non-alcoholic fatty liver disease (NAFLD), recently referred to as “metabolic dysfunction-associated steatotic liver disease” (MASLD), affects 25% of the adult population with no effective drug treatments available. Previous animal studies reported that a polyphenol-rich extract from the Amazonian berry camu-camu (CC) prevented hepatic steatosis in a mouse model of diet-induced obesity. This study aims to determine the impact of CC on hepatic steatosis (primary outcome) and evaluate changes in metabolic and gut microbiota profiles (exploratory outcomes). A randomized, double-blind, placebo-controlled crossover trial is conducted on 30 adults with overweight and hypertriglyceridemia, who consume 1.5 g of CC capsules or placebo daily for 12 weeks. CC treatment decreases liver fat by 7.43%, while it increases by 8.42% during the placebo intervention, showing a significant difference of 15.85%. CC decreases plasma aspartate and alanine aminotransferases levels and promotes changes in gut microbiota composition. These findings support that polyphenol-rich prebiotic may reduce liver fat in adults with overweight, reducing the risk of developing NAFLD. • Camu-camu reduces hepatic steatosis in adults with overweight and hypertriglyceridemia • Camu-camu supplementation decreases plasma AST and ALT levels • Camu-camu supplementation alters gut microbiota composition Agrinier et al. demonstrate that camu-camu (CC) supplementation reduces liver fat and improves liver injury markers in individuals with overweight and hypertriglyceridemia. CC also alters gut microbiota composition, supporting its potential as a polyphenol-rich prebiotic supplement for reducing non-alcoholic fatty liver disease risk.
50
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony Bolger, Marc Lohse, Björn Usadel · Bioinformatics · 2014 · 69.7K citations · Full text
Fast gapped-read alignment with Bowtie 2
Ben Langmead, Steven L. Salzberg · Nature Methods · 2012 · 61.1K citations
DADA2: High-resolution sample inference from Illumina amplicon data
Benjamin J. Callahan, Paul J. McMurdie, Michael Rosen et al. · Nature Methods · 2016 · 36.3K citations